In order to study the tumor progression, including EMT, sustained by upregulation of CD 163 and CD 204 (M2‐TAM) and STAT3, NF‐κB in TME of 100 patients with CC ̧, we analyzed the protein expression of these markers by IH. The gene discussed is NFKB1; the disease is neoplasm.